about
Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI.Patent foramen ovale in patients with sickle cell disease and stroke: case presentations and review of the literature.Sexual dimorphism in BDNF signaling after neonatal hypoxia-ischemia and treatment with necrostatin-1.Patent foramen ovale in adults with sickle cell disease and stroke.
P50
description
researcher ORCID ID = 0000-0002-4137-7635
@en
wetenschapper
@nl
name
S Razdan
@ast
S Razdan
@en
S Razdan
@nl
type
label
S Razdan
@ast
S Razdan
@en
S Razdan
@nl
prefLabel
S Razdan
@ast
S Razdan
@en
S Razdan
@nl
P106
P31
P496
0000-0002-4137-7635